Civorebrutinib
Civorebrutinib (WS-413) is a Bruton's tyrosine kinase inhibitor with antineoplastic effect[1].
Product Specifications
CAS Number
2155853-43-1
Product Name Alternative
WS-413
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/civorebrutinib.html
Solubility
10 mM in DMSO
Smiles
ClC(C=C1)=CN=C1OC2=CC=C(C3=NN([C@@H]4CCC5(CC5)N(C#N)C4)C(N)=C3C(N)=O)C=C2
Molecular Formula
C23H22ClN7O2
Molecular Weight
463.92
References & Citations
[1]Wu Y, et al. 5-Aminopyrazole carboxamide derivative as BTK inhibitor and its preparation. World Intellectual Property Organization, WO2017198050 A1 2017-11-23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GAF-411-10 1 mL
Colloidal Gold Conjugated Goat Affinity Purified Antibody to Bovine IgG, 10nm
Sign In for Pricing
View Details 
LY419637 100 µg
CD26 (DPP4) (NM_001935) Human Over-expression Lysate
Sign In for Pricing
View Details 